Trade.Information

Toshiba and first chemical, medical application DNA tip/chip cooperation development (Toshiba)

Toshiba announced production and sale approval application concerning the DNA tip/chip which was developed with the 15th and the first chemical etc jointly, as a medical supply for external diagnosis that it did. Depending upon this DNA tip/chip, type of the virus which becomes cause of the uterus neck cancer is distinguished.
　The toshiba [hokuto] electron which bears production receives medical supply production permission in 2007 February, already completing the mass production line. It is approved and starts circumstance and sale. 3 corporations in the future aim toward the utilization of the DNA tip/chip which designates the infection symptom and the side effect etc of the medicine as the object.
　Those which you inspect whether the DNA tip/chip it locks the DNA molecule of the one chain of plural kinds on the glass and silicon, to one chain in the sample by the fact that it reacts with DNA which is converted, there is intended DNA in the sample. The former DNA tip/chip irradiates the laser, but those which measure the fluorescence which is detected, as for the tip/chip which this time was developed adopting electric current detection system. Because the fluorescent sign is not needed in detection, the device being small-sized, low it reaches cost.

News Inside News;

About the DNA tip/chip for distinction

　The DNA tip/chip, on the baseplate of the glass and silicon, being something which locks the DNA molecule of the one chain of plural kinds, it can inspect whether or not by the fact that you inspect whether or not to one chain in the sample it connects with DNA which it converts, intended DNA exists in the sample. The majority of the DNA tips/chips which presently are marketed irradiates the laser and we adopt the fluorescent detection system which measures fluorescence, the device is large-sized, because the tip/chip and the inspecting system are high price, it had become the cause of obstructing the spread to other than research use.
　As for the electric current detection system which Toshiba developed, because optical system is not needed in detection, device constitution of the sensing station quite becomes simple and miniaturization is easy. Operation being simple, inspection precision is high, in addition to the fact that measurement is quick, introduction cost to the hospital is cheap, there is an advantage such that the diagnostic cost per 1 times can be held down low.

Details of development

　Toshiba and the first chemical directing to the commercialization of the medical application DNA tip/chip, the electric current detection type DNA tip/chip which Toshiba developed from 2004 January and combining the know-how of the external diagnostic medicine which the first chemical has, advanced preparation. In 2006 July, it agreed to joint developing the external diagnostic medicine which uses the DNA tip/chip and commercializing, it concluded “DNA tip/chip joint development and the basic agreement contract regarding commercialization” at 3 corporations which also the DNA tip/chip and the Toshiba [hokuto] electron which takes charge of the production of the measurement equipment add.
　Under this joint development contract, [hitopapiromauirusu] which is cause of the uterus neck cancer (below, HPV) type the DNA tip/chip for external diagnosis which is distinguished was developed. After that, being joint with the medical institution in 2007, it accepted the fact that the clinical Osamu 験 which goes ends, this each time, did the medicine thing application of the medical supply for external diagnosis from the first chemical.

Summary of each company

First chemical corporation (the Sekisui chemical group)

Head office　 ： The tokyo Chuo Ku Nihonbashi 3-13-5 KDX Nihonbashi 313 buildings
Representative ： The grommet which Ichiro reed rice field Noboru Representative President (the [a] does and is it is, the [chi] wax)
Capital ： 12,000,075,000,000 Yen
The number of employees ： 609 names (2007 3 end of the month)
Main business ： Clinical examination medicine business, chemical business, reagent business and medicine movement research business for research

Corporation Toshiba

Head office　 ： The tokyo Minato-ku Shibaura 1-1-1
Representative ： Thick Satoshi Nisida President typical execution part (it does and is it does thickly)
Capital ： 274,900,000,000 Yen
The number of employees ： 31,951 names (2007 April)
Main business ： Digital products business, electronic device business and social below business etc

The toshiba [hokuto] electronic corporation

Head office ： The hokkaido Asahikawa Itiminami 5 provision 23 Chome 1975 addresses
Representative ： Siyouzi Kanto Representative President (as for can and skillfulness [ru])
Capital ： 989,000,000 Yen
The number of employees ： 365 names (2007 April)
Main business ： Picture tube business, flexible circuit baseplate business, magnetron business and thermal print head business etc

Future Plan-
In the future, 3 corporations continue to the DNA tip/chip for HPV type distinction, the infection symptom, keep advancing the use of the cancer and the medicine and the utilization of the DNA tip/chip for external diagnosis which deals with the gene diagnosis of the side effect

Contact-
email: hdqchotatsuc@dx.toshiba.co.jp
Please be sure to make your suggestion or inquiry as concrete as possible.When mailing from outside Japan, please indicate your country or area, so that we can be sure to deliver your message to the right person.
FAX
+81-3-3456-6619
Address
Corporate Procurement Division, TOSHIBA CORPORATION
1-1, Shibaura 1-chome, Minato-ku, Tokyo 105-8001, Japan

Notes-
(Human Papilloma Virus)
With the virus which becomes cause of the uterus neck cancer, virus type of 13 where connection of carcinogenesis is high is known

Release link: http://www.toshiba.co.jp/index.htm